IP Library Granted Patent US 7,670,815
Granted Patent B2
US 7,670,815 · App. 12/054,227 · Granted Mar 2, 2010

N-acetylglucosaminyltransferase Vb coding sequences, recombinant cells and methods

Assignee: University of Georgia Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,670,815
App. No.
12/054,227
Granted
Mar 2, 2010
Kind
B2
Abstract

A previously unknown mammalian UDP-N-acetylglucosamine:α-6-D-mannoside β-1,6-N-acetylglucosaminyl-transferase (termed GlcNAc T-Vb herein) coding sequence, protein, recombinant host cells and antibodies which specifically bind GlcNAc T-Vb are described. In particular, GlcNAc T-Vb of mouse is disclosed.

Claims (20)

1. An isolated non-naturally occurring DNA molecule comprising a nucleotide sequence encoding a polypeptide having N-acetylglucosaminyl transferase V-b activity, said nucleotide sequence having at least 95% homology with nucleotides 369-2744 of SEQ ID NO:3.

2. The DNA molecule of claim 1 , wherein said nucleotide sequence is from mouse.

3. The DNA molecule of claim 2 , wherein said polypeptide comprises the amino acid sequence of SEQ ID NO:4.

4. The DNA molecule of claim 3 , wherein said nucleotide sequence is the sequence set forth in nucleotides 369 to 2744 of SEQ ID NO:3.

5. The DNA molecule comprising the DNA sequence of claim 1 and further comprising an exogenous nucleotide sequence.

6. The DNA molecule of claim 5 , wherein said exogenous nucleotide sequence is an expression vector.

7. An isolated recombinant host cell comprising the DNA molecule of claim 6 .

8. The recombinant cell of claim 7 , wherein said cell is a bacterial cell.

9. The recombinant cell of claim 8 , wherein said bacterial cell is Escherichia coli.

10. The recombinant cell of claim 7 , wherein said cell is a mammalian cell.

11. The recombinant cell of claim 10 , wherein said cell is selected from the group consisting of a COS-7 cell, a HEK-293 cell and a 3T3 cell.

12. The recombinant cell of claim 7 , wherein said cell is an insect cell, a yeast cell or a fungal cell.

13. A recombinant host cell comprising the DNA molecule of claim 3 .

14. The recombinant cell of claim 13 , wherein said cell is a bacterial cell.

15. The recombinant cell of claim 14 , wherein said bacterial cell is Escherichia coli.

16. The recombinant cell of claim 13 , wherein said cell is a mammalian cell.

17. The recombinant cell of claim 16 , wherein said cell is selected from the group consisting of a COS-7 cell, a HEK-293 cell and a 3T3 cell.

18. The recombinant cell of claim 13 , wherein said cell is an insect cell, a yeast cell or a fungal cell.

19. A method of producing a polypeptide having N-Acetylglucosaminyl transferase V-b activity, said method comprising the step of culturing the recombinant cell of claim 7 under conditions suitable for expression of said GlcNAc T-Vb.

20. A method of producing a polypeptide having N-Acetylglucosaminyl transferase V-b activity, said method comprising the step of culturing the recombinant cell of claim 13 under conditions suitable for expression of said GlcNAc T-Vb.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 7, 2010
From: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024195/0461 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2008
From: PIERCE, JAMES M.; KAMAR, MARIA; LEE, JIN-KYU; KANEKO, MIKA
To: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION
Reel/Frame 020721/0331 →
Continuity (4)
Division 1097205300 · Oct 22, 2004
Continuation In Part PCTUS031275900 · Apr 23, 2003
Provisional Application 6037517200 · Apr 23, 2002
Related Publication 20090042247A1 · Feb 12, 2009